Innoviva (INVA) Other Operating Expenses (2013 - 2023)

Innoviva (INVA) has 6 years of Other Operating Expenses data on file, last reported at -$11.8 million in Q3 2023.

• Quarterly Other Operating Expenses rose 96.04% year-over-year to -$11.8 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was -$11.8 million (up 95.43% YoY) and the FY2022 annual result came in at -$60.6 million, up 13.67% from the prior year.
• Other Operating Expenses declined to -$11.8 million in Q3 2023, from $36.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $62.1 million in Q2 2022 to a low of -$296.7 million in Q3 2022.
• A 4-year average of -$40.6 million and a median of -$4.4 million in 2023 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 150.99% — and 2023, when it soared 96.04%.
• Tracing INVA's Other Operating Expenses over 4 years: stood at -$33.1 million in 2020, then sank by 256.9% to -$118.2 million in 2021, then sank by 150.99% to -$296.7 million in 2022, then soared by 96.04% to -$11.8 million in 2023.
• The last three Other Operating Expenses figures came in at -$11.8 million (Q3 2023), $36.7 million (Q2 2023), and $2.9 million (Q1 2023), per Business Quant data.